Screening for silent myocardial ischaemia in patients with type 2 diabetes mellitus: A quest to improve selection of the target screening population

Acta Cardiologica

Volumn 66, Issue 6, 2011, Pages 715-720

  de Keyzer, Eva ^a   Kerkhove, Dirk ^a   van Camp, Guy ^a   de Sutter, Johan ^b   Achtergael, Wim ^a   Keymeulen, Bart ^a   Weytjens, Caroline ^a  

^a UNIVERSITY HOSPITAL BRUSSELS   (Belgium)

^b AZ Maria Middelares   (Belgium)

Author keywords

Diabetes mellitus; Exercise; Screening; Silent ischaemia

Indexed keywords

LOW DENSITY LIPOPROTEIN CHOLESTEROL;

ADULT; ARTICLE; BLOOD ANALYSIS; BRADYCARDIA; CARDIAC PATIENT; CARDIOVASCULAR RISK; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; CORONARY ARTERY DISEASE; DIABETIC PATIENT; DIAGNOSTIC VALUE; EXERCISE TEST; FAMILY HISTORY; FEMALE; HUMAN; LIFE EXPECTANCY; LIPOPROTEIN BLOOD LEVEL; MAJOR CLINICAL STUDY; MALE; MEDICAL HISTORY; MULTIVARIATE LOGISTIC REGRESSION ANALYSIS; NON INSULIN DEPENDENT DIABETES MELLITUS; PHYSICAL EXAMINATION; PREVALENCE; SCREENING; SILENT MYOCARDIAL ISCHEMIA; SYSTOLIC BLOOD PRESSURE; URINALYSIS;

EID: 83755195843     PISSN: 00015385     EISSN: None     Source Type: Journal    
DOI: 10.1080/ac.66.6.2136954     Document Type: Article

References (21)

1. Beller GA. Noninvasive screening for coronary atherosclerosis and silent ischemia in asymptomatic type 2 diabetic patients: is it appropriate and cost-effective? J Am Cardiol 2007; 49: 1918-23.
2. DeStefano F, Ford ES, Newman J, Stevenson JM, Wetterhall SF, Anda RF, Vinicor F. Risk factors for coronary heart disease mortality among persons with diabetes. Ann Epidemiol 1993; 3: 27-34.
3. Haffner SM, Lehto S, Ronnemaa T, Pyorala K, Laakso M. Mortality from coronary heart disease in subjects with type 2 diabetes and in nondiabetic subjects with and without prior myocardial infarction. N Engl J Med 1998; 339: 229-34.
4. Bate KL, Jerums G. 3: Preventing complications of diabetes. Med J Aust 2003; 179: 498-503.
5. Wild S, Roglic G, Green A, Sicree R, King H. Global prevalence of diabetes: estimates for the year 2000 and projections for 2030. Diabetes Care 2004; 27: 1047-53.
6. Albers AR, Krichavsky MZ, Balady GJ. Stress testing in patients with diabetes mellitus: diagnostic and prognostic value. Circulation 2006; 113: 583-92.
7. Falcone C, Nespoli L, Geroldi D, Gazzaruso C, Buzzi MP, Auguadro C, Tavazzi L, Schwartz PJ. Silent myocardial ischemia in diabetic and nondiabetic patients with coronary artery disease. Int J Cardiol 2003; 90: 219-27.
8. Di Carli MF, Hachamovitch R. Should we screen for occult coronary artery disease among asymptomatic patients with diabetes? J Am Coll Cardiol 2005; 45: 50-3.
9. May O, Arildsen H, Damsgaard EM, Mickley H. Cardiovascular autonomic neuropathy in insulin-dependent diabetes mellitus: prevalence and estimated risk of coronary heart disease in the general population. J Intern Med 2000; 248: 483-91.
10. Wackers FJ, Young LH, Inzucchi SE, Chyun DA, Davey JA, Barrett EJ, Taillefer R, Wittlin SD, Heller GV, Filipchuk N, Engel S, Ratner RE, Iskandrian AE. Detection of Ischemia in Asymptomatic Diabetics Investigators. Diabetes Care 2004; 27: 1954-61.
11. Inoguchi T, Yamashita T, Umeda F, Mihara H, Nakagaki O, Takada K, Kawano T, Murao H, Doi T, Nawata H. High incidence of silent myocardial ischemia in elderly patients with non insulin-dependent diabetes mellitus. Diabetes Res Clin Pract 2000; 47: 37-44.
12. American Diabetes Association: Consensus development conference on the diagnosis of coronary heart disease in people with diabetes. Diabetes Care 1998; 21: 1551-9.
13. Chaitman BR, Hardison RM, Adler D, Gebhart S, Grogan M, Ocampo S, Sopko G, Ramires JA, Schneider D, Frye RL; Bypass Angioplasty Revascularization Investigation 2 Diabetes (BARI 2D) Study Group. The Bypass Angioplasty Revascularization Investigation 2 Diabetes randomized trial of different treatment strategies in type 2 diabetes mellitus with stable ischemic heart disease: impact of treatment strategy on cardiac mortality and myocardial infarction. Circulation 2009; 120: 2529-40.
14. Young LH, Wackers FJ, Chyun DA, Davey JA, Barrett EJ, Taillefer R, Heller GV, Iskandrian AE, Wittlin SD, Filipchuk N, Ratner RE, Inzucchi SE. Cardiac outcomes after screening for asymptomatic coronary artery disease in patients with type 2 diabetes: the DIAD study: a randomized controlled trial. JAMA 2009; 301: 1547-55.
15. Leal J, Gray AM, Clarke PM. Development of life-expectancy tables for people with type 2 diabetes. Eur Heart J 2009; 30: 834-9.
16. Bacci S, Villella M, Villella A, Langialonga T, Grilli M, Rauseo A, Mastroianno S, De Cosmo S, Fanelli R, Trischitta V. Screening for silent myocardial ischaemia in type 2 diabetic patients with additional atherogenic risk factors: applicability and accuracy of the exercise stress test. Eur J Endocrinol 2002; 147: 649-54.
17. Blandine JD, Bernard S, Habib G, Bory M, Vague P, Lassman-Vague V. Silent myocardial ischemia in patients with diabetes: who to screen. Diabetes Care 1999; 22: 1396-1400.
18. Maser RE, Mitchell BD, Vinik AL, Freeman R. The association between cardiovascular autonomic neuropathy and mortality in individuals with diabetes: a meta-analysis. Diabetes Care 2003; 26: 1895-1901.
19. Buse J, Ginsberg H, Bakris G, Clark NG, Costa F, Eckel RH, Fonseca V, Gerstein H, Grundy SM, Nesto RW, Pignone MP, Plutzky J, Porte D, Redberg R, Stritzel KF, Stone NJ. Primary prevention of cardiovascular diseases in people with diabetes mellitus. Circulation 2007; 115: 114-26.
20. Bax J, Young LH, Frye RL, Bonow RO, Steinberg HO, Barrett EJ. Screening for coronary artery disease in patients with diabetes. Diabetes Care 2007; 30: 2729-36.
21. Laukkanen JA, Mäkikallio TH, Rauramaa R, Kurl S. Asymptomatic ST-segment depression during exercise testing and the risk of sudden cardiac death in middle-aged men: a population-based follow-up study. Eur Heart J 2009; 30: 558-65.